Get ADRB2 Genotyping for Beta2 Agonist Responsiveness testing for only $138 USD. Discover your genetic response to asthma medications with our advanced PCR sequencing. Available in New York
Get the 5-Fluorouracil (5-FU) Toxicity Test for only $250 USD in USA. This essential pharmacogenomic test analyzes DPYD gene variants to predict severe toxicity risks before cancer chemotherapy. Available in New York 5-Fluorouracil (5-FU) Toxicity Test Original price was: $376.Current price is: $250.
Get the CYP2C19 Genotyping Test for only $262 USD (regular $450) across USA. This pharmacogenomics test helps determine your body's ability to metabolize medications like clopidogrel CYP2C19 Genotyping Test Original price was: $450.Current price is: $262.
Sale!

ADRB2 Genotyping for Beta2 Agonist Responsiveness Test

Original price was: $188.Current price is: $138.

-27%

The ADRB2 Genotyping for Beta2 Agonist Responsiveness Test is a cutting-edge pharmacogenomic analysis that examines genetic variations in the ADRB2 gene to determine individual response to beta2-agonist medications commonly used for asthma and respiratory conditions. This test provides crucial insights into how your body metabolizes and responds to these important bronchodilators, helping healthcare providers optimize medication selection and dosing for maximum therapeutic benefit while minimizing side effects. By identifying specific genetic polymorphisms, the test can predict whether patients will experience optimal response, reduced effectiveness, or potential adverse reactions to beta2-agonist therapies. The comprehensive analysis costs $138 USD and delivers results within 10 working days, offering valuable guidance for personalized asthma management and treatment planning.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ADRB2 Genotyping for Beta2 Agonist Responsiveness Test

Understanding ADRB2 Genetic Testing

The ADRB2 Genotyping for Beta2 Agonist Responsiveness Test represents a breakthrough in personalized medicine for respiratory conditions. This advanced pharmacogenomic analysis examines specific genetic variations in the beta-2 adrenergic receptor gene (ADRB2), which plays a critical role in how your body responds to commonly prescribed asthma medications known as beta2-agonists.

Genetic variations in the ADRB2 gene can significantly impact medication effectiveness, with certain polymorphisms leading to reduced bronchodilator response or increased risk of adverse effects. By understanding your unique genetic profile, healthcare providers can make more informed decisions about medication selection and dosing strategies.

What This Test Measures

Our comprehensive ADRB2 genotyping test analyzes specific single nucleotide polymorphisms (SNPs) within the ADRB2 gene that have been clinically validated to affect beta2-agonist responsiveness:

  • Arg16Gly polymorphism (rs1042713)
  • Gln27Glu polymorphism (rs1042714)
  • Thr164Ile polymorphism (rs1800888)

These genetic variations influence receptor function, down-regulation patterns, and overall medication efficacy, providing crucial insights for treatment optimization.

Who Should Consider ADRB2 Genotyping?

This test is particularly valuable for individuals experiencing:

  • Suboptimal response to standard beta2-agonist therapy
  • Frequent asthma exacerbations despite medication use
  • History of medication side effects or intolerance
  • Poorly controlled asthma symptoms
  • Need for frequent rescue inhaler use
  • Planning long-term asthma management strategies

Clinical Indications Include:

  • Patients with moderate to severe asthma
  • Individuals requiring regular bronchodilator therapy
  • Those with treatment-resistant respiratory symptoms
  • Patients experiencing medication-related side effects
  • Individuals considering long-acting beta2-agonist therapy

Benefits of ADRB2 Genetic Testing

Understanding your genetic profile offers numerous advantages for asthma management:

  • Personalized Treatment Plans: Tailor medication selection based on your genetic predisposition
  • Optimized Dosing Strategies: Adjust medication dosages for maximum effectiveness
  • Reduced Side Effects: Minimize adverse reactions through genetic-guided prescribing
  • Improved Symptom Control: Achieve better asthma control with genetically appropriate medications
  • Enhanced Quality of Life: Experience fewer asthma exacerbations and hospital visits
  • Cost-Effective Care: Avoid ineffective medications and associated healthcare costs

Understanding Your Test Results

Your ADRB2 genotyping results will provide detailed information about your genetic variations and their clinical implications:

Result Interpretation Guidelines:

  • Favorable Genotype: Indicates optimal response to standard beta2-agonist therapy
  • Intermediate Response: May require dosage adjustments or combination therapy
  • Reduced Response: Suggests alternative medication classes may be more effective
  • Increased Risk Profile: May indicate higher likelihood of adverse effects

All results include comprehensive interpretation by our molecular diagnostics specialists and clinical recommendations for your healthcare provider. It’s essential to discuss your results with your physician to develop the most appropriate treatment plan.

Test Details and Pricing

Test Component Details
Test Name ADRB2 Genotyping for Beta2 Agonist Responsiveness Test
Discount Price $138 USD
Regular Price $188 USD
Turnaround Time Sample by 11 am; Report in 10 Working Days
Sample Type 4 mL (2 mL min.) whole Blood in 1 Lavender top (EDTA) Tube
Shipping Instructions Ship refrigerated. DO NOT FREEZE
Preparation No Special preparation required
Testing Method PCR Sequencing
Department Molecular Diagnostics

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities nationwide. Our extensive network ensures accessible genetic testing services wherever you are located.

Take Control of Your Asthma Treatment

Don’t settle for trial-and-error medication approaches. Our ADRB2 genotyping test provides scientifically validated insights to optimize your asthma treatment strategy. With results available in just 10 working days and comprehensive clinical interpretation, you’ll receive the personalized guidance needed for effective respiratory care.

Ready to optimize your asthma treatment? Book your ADRB2 Genotyping test today by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward personalized respiratory care and improved quality of life.

SKU: 87 Category:

Related products